Johnson & Johnson Gets U.S., Europe Approval for Veritas Vision System
April 21 2021 - 7:00AM
Dow Jones News
By Colin Kellaher
Johnson & Johnson on Wednesday said it received U.S. and
European regulatory approval for its Veritas Vision System, which
is aimed at improving the phacoemulsification technique used in
cataract surgery.
The New Brunswick, N.J., healthcare giant said the Veritas
system features technologies that allow surgeons to guide through
any lens density with less surge and more stability, adding that it
also provides advancements in ergonomics to further enhance
usability during cataract surgery.
Phacoemulsification, the most common cataract surgery technique,
allows ophthalmologists to emulsify and remove the eye's internal
lens when it has become cloudy from cataracts, Johnson &
Johnson said.
The company said it plans a full commercial launch of the
Veritas system globally later this year.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 21, 2021 06:45 ET (10:45 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024
